+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosimilars Market 2025-2029- Product Image
Biosimilars Market 2025-2029- Product Image
New

Biosimilars Market 2025-2029

  • PDF Icon

    Report

  • 219 Pages
  • February 2025
  • Region: Global
  • TechNavio
  • ID: 5395376
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The biosimilars market is forecasted to grow by USD 117.67 billion during 2024-2029, accelerating at a CAGR of 34.2% during the forecast period. The report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by price advantage of biosimilars over biologics, patent expiry of major biologics, and government initiatives to increase use of biosimilar medicines.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The biosimilars market is segmented as below:

By Product Type

  • Monoclonal antibodies
  • Insulin
  • Human growth hormone
  • Others

By Application

  • Oncology and hematology
  • Endocrinology
  • Immunology
  • Nephrology

By Manufacturing Type

  • In-house manufacturing
  • Contract manufacturing

By Geographical Landscape

  • Europe
  • North America
  • Asia
  • Rest of World (ROW)
This study identifies the willingness to switch to biosimilars as one of the prime reasons driving the biosimilars market growth during the next few years. Also, therapeutic interchangeability regulations for biosimilars across countries and patent dance will lead to sizable demand in the market.

The report on the biosimilars market covers the following areas:

  • Biosimilars Market sizing
  • Biosimilars Market forecast
  • Biosimilars Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., DR Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter PLC, Halozyme Therapeutics Inc., Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Manufacturing Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Biosimilars Market 2019 - 2023
Historic Market Size - Data Table on Global Biosimilars Market 2019 - 2023 ($ million)
5.2 Product Type segment analysis 2019 - 2023
Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Manufacturing Type segment analysis 2019 - 2023
Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 AI Impact on Global Biosimilars Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product Type
8.1 Market segments
Chart on Product Type - Market share 2024-2029 (%)
Data Table on Product Type - Market share 2024-2029 (%)
8.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
8.3 Monoclonal antibodies - Market size and forecast 2024-2029
Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
8.4 Insulin - Market size and forecast 2024-2029
Chart on Insulin - Market size and forecast 2024-2029 ($ million)
Data Table on Insulin - Market size and forecast 2024-2029 ($ million)
Chart on Insulin - Year-over-year growth 2024-2029 (%)
Data Table on Insulin - Year-over-year growth 2024-2029 (%)
8.5 Human growth hormone - Market size and forecast 2024-2029
Chart on Human growth hormone - Market size and forecast 2024-2029 ($ million)
Data Table on Human growth hormone - Market size and forecast 2024-2029 ($ million)
Chart on Human growth hormone - Year-over-year growth 2024-2029 (%)
Data Table on Human growth hormone - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by Application
9.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
9.3 Oncology and hematology - Market size and forecast 2024-2029
Chart on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology and hematology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology and hematology - Year-over-year growth 2024-2029 (%)
9.4 Endocrinology - Market size and forecast 2024-2029
Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
9.5 Immunology - Market size and forecast 2024-2029
Chart on Immunology - Market size and forecast 2024-2029 ($ million)
Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
Chart on Immunology - Year-over-year growth 2024-2029 (%)
Data Table on Immunology - Year-over-year growth 2024-2029 (%)
9.6 Nephrology - Market size and forecast 2024-2029
Chart on Nephrology - Market size and forecast 2024-2029 ($ million)
Data Table on Nephrology - Market size and forecast 2024-2029 ($ million)
Chart on Nephrology - Year-over-year growth 2024-2029 (%)
Data Table on Nephrology - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by Manufacturing Type
10.1 Market segments
Chart on Manufacturing Type - Market share 2024-2029 (%)
Data Table on Manufacturing Type - Market share 2024-2029 (%)
10.2 Comparison by Manufacturing Type
Chart on Comparison by Manufacturing Type
Data Table on Comparison by Manufacturing Type
10.3 In-house manufacturing - Market size and forecast 2024-2029
Chart on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
Data Table on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
Chart on In-house manufacturing - Year-over-year growth 2024-2029 (%)
Data Table on In-house manufacturing - Year-over-year growth 2024-2029 (%)
10.4 Contract manufacturing - Market size and forecast 2024-2029
Chart on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
Data Table on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
Chart on Contract manufacturing - Year-over-year growth 2024-2029 (%)
Data Table on Contract manufacturing - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Manufacturing Type
Market opportunity by Manufacturing Type ($ million)
Data Table on Market opportunity by Manufacturing Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.8 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.13 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 UAE - Market size and forecast 2024-2029
Chart on UAE - Market size and forecast 2024-2029 ($ million)
Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Chart on UAE - Year-over-year growth 2024-2029 (%)
Data Table on UAE - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
15.6 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
SWOT
15.7 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
SWOT
15.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
15.9 Celltrion Healthcare Co. Ltd.
Celltrion Healthcare Co. Ltd. - Overview
Celltrion Healthcare Co. Ltd. - Business segments
Celltrion Healthcare Co. Ltd. - Key offerings
Celltrion Healthcare Co. Ltd. - Segment focus
SWOT
15.10 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
15.12 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
SWOT
15.13 Gedeon Richter Plc
Gedeon Richter Plc - Overview
Gedeon Richter Plc - Business segments
Gedeon Richter Plc - Key offerings
Gedeon Richter Plc - Segment focus
SWOT
15.14 Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc. - Overview
Halozyme Therapeutics Inc. - Product / Service
Halozyme Therapeutics Inc. - Key offerings
SWOT
15.15 Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. - Overview
Intas Pharmaceuticals Ltd. - Product / Service
Intas Pharmaceuticals Ltd. - Key offerings
SWOT
15.16 Mabion S.A.
Mabion S.A. - Overview
Mabion S.A. - Product / Service
Mabion S.A. - Key offerings
SWOT
15.17 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
15.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Biosimilars Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product Type - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product Type - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product Type
Exhibits 41: Data Table on Comparison by Product Type
Exhibits 42: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Insulin - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Insulin - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Insulin - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Insulin - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Human growth hormone - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Human growth hormone - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Human growth hormone - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Human growth hormone - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 58: Market opportunity by Product Type ($ million)
Exhibits 59: Data Table on Market opportunity by Product Type ($ million)
Exhibits 60: Chart on Application - Market share 2024-2029 (%)
Exhibits 61: Data Table on Application - Market share 2024-2029 (%)
Exhibits 62: Chart on Comparison by Application
Exhibits 63: Data Table on Comparison by Application
Exhibits 64: Chart on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Oncology and hematology - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Oncology and hematology - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Immunology - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Immunology - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Immunology - Year-over-year growth 2024-2029 (%)
Exhibits 76: Chart on Nephrology - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Nephrology - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Nephrology - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Nephrology - Year-over-year growth 2024-2029 (%)
Exhibits 80: Market opportunity by Application ($ million)
Exhibits 81: Data Table on Market opportunity by Application ($ million)
Exhibits 82: Chart on Manufacturing Type - Market share 2024-2029 (%)
Exhibits 83: Data Table on Manufacturing Type - Market share 2024-2029 (%)
Exhibits 84: Chart on Comparison by Manufacturing Type
Exhibits 85: Data Table on Comparison by Manufacturing Type
Exhibits 86: Chart on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on In-house manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on In-house manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Contract manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Contract manufacturing - Year-over-year growth 2024-2029 (%)
Exhibits 94: Market opportunity by Manufacturing Type ($ million)
Exhibits 95: Data Table on Market opportunity by Manufacturing Type ($ million)
Exhibits 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 99: Chart on Geographic comparison
Exhibits 100: Data Table on Geographic comparison
Exhibits 101: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 157: Market opportunity By Geographical Landscape ($ million)
Exhibits 158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 159: Impact of drivers and challenges in 2024 and 2029
Exhibits 160: Overview on criticality of inputs and factors of differentiation
Exhibits 161: Overview on factors of disruption
Exhibits 162: Impact of key risks on business
Exhibits 163: Companies covered
Exhibits 164: Company ranking index
Exhibits 165: Matrix on companies position and classification
Exhibits 166: AbbVie Inc. - Overview
Exhibits 167: AbbVie Inc. - Product / Service
Exhibits 168: AbbVie Inc. - Key news
Exhibits 169: AbbVie Inc. - Key offerings
Exhibits 170: SWOT
Exhibits 171: Amgen Inc. - Overview
Exhibits 172: Amgen Inc. - Product / Service
Exhibits 173: Amgen Inc. - Key news
Exhibits 174: Amgen Inc. - Key offerings
Exhibits 175: SWOT
Exhibits 176: Biocon Ltd. - Overview
Exhibits 177: Biocon Ltd. - Business segments
Exhibits 178: Biocon Ltd. - Key offerings
Exhibits 179: Biocon Ltd. - Segment focus
Exhibits 180: SWOT
Exhibits 181: Biogen Inc. - Overview
Exhibits 182: Biogen Inc. - Product / Service
Exhibits 183: Biogen Inc. - Key news
Exhibits 184: Biogen Inc. - Key offerings
Exhibits 185: SWOT
Exhibits 186: Boehringer Ingelheim International GmbH - Overview
Exhibits 187: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 188: Boehringer Ingelheim International GmbH - Key news
Exhibits 189: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 190: SWOT
Exhibits 191: Celltrion Healthcare Co. Ltd. - Overview
Exhibits 192: Celltrion Healthcare Co. Ltd. - Business segments
Exhibits 193: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits 194: Celltrion Healthcare Co. Ltd. - Segment focus
Exhibits 195: SWOT
Exhibits 196: Dr Reddys Laboratories Ltd. - Overview
Exhibits 197: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 198: Dr Reddys Laboratories Ltd. - Key news
Exhibits 199: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 200: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 201: SWOT
Exhibits 202: F. Hoffmann La Roche Ltd. - Overview
Exhibits 203: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 204: F. Hoffmann La Roche Ltd. - Key news
Exhibits 205: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 206: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 207: SWOT
Exhibits 208: Fresenius SE

Executive Summary

The following companies are recognized as the key players in the global biosimilars market: AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter Plc, Halozyme Therapeutics Inc., Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is willingness to switch to biosimilars."

According to the report, one of the major drivers for this market is the price advantage of biosimilars over biologics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • Biocon Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Celltrion Healthcare Co. Ltd.
  • Dr Reddys Laboratories Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fresenius SE and Co. KGaA
  • Gedeon Richter Plc
  • Halozyme Therapeutics Inc.
  • Intas Pharmaceuticals Ltd.
  • Mabion S.A.
  • Novartis AG
  • Pfizer Inc.
  • Samsung Biologics Co. Ltd.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Rituximab Biosimilars Global Market Report 2024 - Product Image

Rituximab Biosimilars Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Pegfilgrastim Biosimilars Global Market Report 2024 - Product Image

Pegfilgrastim Biosimilars Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Biosimilars - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Biosimilars - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Biosimilars Market by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook - Global Forecast up to 2032 - Product Image

Biosimilars Market by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook - Global Forecast up to 2032

  • Report
  • 118 Pages
  • Global
From
Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Biosimilars - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.